证券代码：300705 证券简称：九典制药 债券代码：123223 债券简称：九典转 02 湖南九典制药股份有限公司 投资者关系活动记录表 编号：2025-15 |  | 特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | □现场参观 其他 | | 参与单位名称及 人员姓名 | 国信医药投资者代表共 1 人 | | 时间 | 2025 年 7 月 1 日上午 10:00-11:00 | | 地点 | 公司会议室 | | 上市公司接待人 | 副总经理兼董事会秘书：曾蕾 | | 员姓名 | 证券事务代表：甘荣 | | | 主要采用解答投资者提问的方式进行，主要问题回复如下： | | | 1、公司在市场竞争中有哪些优势？ | | | 回复：在成本端，凭借完整的产业链布局，公司能够自 | | | 主生产原料药和关键辅料，确保产品质量的同时有效控制成 | | | 本。在销售端，公司已建立起全渠道覆盖体系，特别是院外 | | | 市场，已成为业绩增长的新引擎，公司计划继续加大投入， | | 投资者关系活动 ...

证券代码：300705 证券简称：九典制药 回复：公司认为洛索洛芬钠凝胶贴膏单品在院外市场具 有较大的发展潜力。市场数据显示，外用贴膏剂在零售端占 据重要市场份额，表明院外市场对这类产品有稳定的需求。 随着消费者对便捷用药方式的偏好增加，院外市场将成为重 要的增长点。公司将继续加强市场推广和渠道建设，进一步 挖掘院外市场的机会，提升产品渗透率和市场份额。 4、洛索洛芬钠凝胶贴膏和消炎解痛巴布膏有什么区别？ 回复：洛索洛芬钠凝胶贴膏和消炎解痛巴布膏在药物成 分、适应症及处方属性等方面存在显著差异。 洛索洛芬钠凝胶贴膏有效成分是洛索洛芬钠，主要适用 于骨关节炎、肌肉痛、外伤后的肿胀疼痛，为临床肌肉骨骼 系统疼痛提供了一线用药选择。洛索洛芬钠凝胶贴膏为处方 药，需凭医师处方使用。 债券代码：123223 债券简称：九典转 02 湖南九典制药股份有限公司 投资者关系活动记录表 编号：2025-13 | |  特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | □现场参观 其他 | | 参与单位名称及 ...

Market Overview - The transdermal patch industry is experiencing rapid growth due to factors such as an aging population facing chronic pain issues like arthritis and muscle pain, which increases market demand for patch products [2][3] - Public awareness of scientific medication and health management is rising, leading to a preference for convenient and safe external medications like transdermal patches [2][3] Company Advantages - The company benefits from a complete industrial chain, allowing for in-house production of active pharmaceutical ingredients and key excipients, ensuring product quality while controlling costs [3][8] - A comprehensive sales channel system has been established, particularly in the outpatient market, which is a new growth engine for performance [3] - Continuous high investment in R&D enables the company to innovate and expand its product line, enhancing its competitive edge [3][8] Product Strategy - The company is optimistic about the market prospects for its anti-inflammatory and analgesic patches, focusing on OTC channels and leveraging shared sales resources to boost sales [4] - The sales team consists of over 400 personnel, enhancing the company's market reach [5] Marketing and Promotion - Multi-channel collaboration strategies are employed for OTC promotion, integrating online and offline channels, including partnerships with pharmacies and e-commerce platforms [6][10] - The company emphasizes patient education and conducts health seminars to enhance consumer experience and trust [7] Future Directions - The company plans to focus on three key areas: expanding sales channels, particularly in outpatient markets, enhancing brand influence, and increasing R&D efforts for new product development [12][13] - Continuous optimization of production processes and cost control mechanisms will be prioritized to ensure efficient operations and good returns for shareholders [13] M&A Strategy - The company will consider various directions for mergers and acquisitions, focusing on targets that align with its strategic development, enhance market competitiveness, and enrich its product pipeline [11]